Holt Capital Partners’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$223K Hold
1,200
0.04% 144
2025
Q1
$251K Hold
1,200
0.04% 147
2024
Q4
$213K Sell
1,200
-120
-9% -$21.3K 0.03% 149
2024
Q3
$261K Buy
1,320
+20
+2% +$3.95K 0.04% 145
2024
Q2
$223K Sell
1,300
-184
-12% -$31.6K 0.05% 139
2024
Q1
$270K Buy
1,484
+34
+2% +$6.19K 0.04% 144
2023
Q4
$225K Hold
1,450
0.04% 149
2023
Q3
$216K Buy
+1,450
New +$216K 0.04% 145
2023
Q2
Sell
-1,750
Closed -$279K 153
2023
Q1
$279K Hold
1,750
0.06% 133
2022
Q4
$283K Hold
1,750
0.06% 135
2022
Q3
$235K Hold
1,750
0.07% 130
2022
Q2
$268K Hold
1,750
0.06% 138
2022
Q1
$284K Hold
1,750
0.05% 138
2021
Q4
$237K Buy
+1,750
New +$237K 0.04% 155
2016
Q2
Sell
-1,500
Closed -$86K 126
2016
Q1
$86K Buy
+1,500
New +$86K 0.04% 162
2015
Q4
Sell
-1,500
Closed -$82K 112
2015
Q3
$82K Hold
1,500
0.03% 149
2015
Q2
$101K Hold
1,500
0.04% 142
2015
Q1
$88K Hold
1,500
0.04% 151
2014
Q4
$98K Buy
+1,500
New +$98K 0.04% 144
2014
Q3
Sell
-1,500
Closed -$85K 107
2014
Q2
$85K Buy
1,500
+600
+67% +$34K 0.05% 125
2014
Q1
$46K Hold
900
0.03% 182
2013
Q4
$48K Buy
+900
New +$48K 0.03% 181